Anticancer genes: inducers of tumour-specific cell death signalling.
Recent studies have revealed a new class of genes encoding proteins with specific anticancer activity. Upon ectopic expression, these factors cause cell death specifically in tumour cells by apoptosis, autophagy or mitotic catastrophe, yet normal cells are spared. Some of these genes or their encoded proteins are in clinical development and show promising results, and their signalling pathways are currently under intense investigation. Defining these genes as anticancer genes, we review what is known about their functions, the specific cell death signals they induce and the status of cancer therapy approaches that emulate their function. Systematic screening for such anticancer genes might lead to the identification of a repertoire of signalling pathways directed against cellular alterations that are specific for tumour cells.
Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK. s.grimm@imperial.ac.uk <s.grimm@imperial.ac.uk>
Stefan
S
Grimm
Mathieu
M
Noteborn
D000818:Animals; D051017:Apoptosis Regulatory Proteins / Q000235:genetics* / Q000378:metabolism* / Q000627:therapeutic use; D016923:Cell Death; D006801:Humans; D009369:Neoplasms / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology* / Q000628:therapy; D015398:Signal Transduction
D051017:Apoptosis Regulatory Proteins